Specific features that reliably differentiate DLB from AD and normal aging

Neurology

Volumn 62, Issue 2, 2004, Pages 181-187

  Ferman, Tanis J ^a,b   Smith, G E ^a   Boeve, B F ^a   Ivnik, R J ^a   Petersen, R C ^a   Knopman, D ^a   Graff Radford, N ^a   Parisi, J ^a   Dickson, D W ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DELIRIUM; DEMENTIA; DEMENTIA WITH LEWY BODY; DISEASE ASSOCIATION; DROWSINESS; FEMALE; HALLUCINATION; HUMAN; LETHARGY; LEWY BODY; MAJOR CLINICAL STUDY; MALE; PARKINSONISM; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; REM SLEEP; SPEECH DISORDER; AROUSAL; COMPARATIVE STUDY; DIFFUSE LEWY BODY DISEASE; EXTRAPYRAMIDAL SYNDROME; HOSPITALIZATION; MIDDLE AGED; PARASOMNIA; PHYSIOLOGY; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; SLEEP STAGE; SOMNOLENCE;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AROUSAL; BASAL GANGLIA DISEASES; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HALLUCINATIONS; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REM SLEEP BEHAVIOR DISORDER; SEVERITY OF ILLNESS INDEX; SLEEP STAGES; SPEECH DISORDERS;

EID: 0842304136     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.62.2.181     Document Type: Article

References (39)

1. McKeith I, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
2. McKeith I, Perry R, Fairbairn A, Jabeen S, Perry E. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-922.
3. Lopez O, Hamilton R, Becker J, Wisniewski S, Kaufer D, DeKosky S. Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies. Neurology 2000;44:1780-1787.
4. Hohl U, Tiraboschi P, Hansen L, Thal L, Corey-Bloom J. Diagnostic accuracy of dementia with Lewy bodies. Arch Neurol 2000;57:347-351.
5. Verghese J, Crystal H, Dickson D, Lipton R. Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology 1999;53:1974-1982.
6. McKeith IG, Ballard CG, Perry RH, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000;54:1050-1058.
7. Mega M, Masterman D, Benson D, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 1996;47:1403-1409.
8. Walker MP, Ayre G, Cummings JL, et al. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology 2000;54:1616-1624.
9. Walker MP, Ayre GA, Cummings JL, et al. The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Br J Psychiatry 2000;177:252-256.
10. Inouye SK, Van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990;113:941-948.
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadian EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
12. Boeve BF, Silber MH, Ferman TJ, et al. REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology 1998;51:363-370.
13. Ferman TJ, Boeve BF, Smith GE, et al. REM sleep behavior disorder and dementia: cognitive differences when compared with AD. Neurology 1999;52:951-957.
14. Ferman TJ, Boeve BF, Smith GE, et al. Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations. J Int Neuropsychol Soc 2002;8:907-914.
15. American Sleep Disorders Association. The International Classification of Sleep Disorders Diagnostic and Coding Manual. Rochester, MN: American Sleep Disorders Association, 1997.
16. Weintraub S. The Record of Independent Living: an informant-completed measure of activities of daily living and behavior in elderly patients with cognitive impairment. Am J Alzheimer Care Relat Disord 1986;7:35-39.
17. Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992;15:376-381.
18. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory. Comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
19. Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F. Unified Parkinson's Disease Rating Scale characteristics and structure: The Cooperative Multicentric Group. Mov Disord 1994;9:76-83.
20. Reisberg B, Ferris S, deLeon M, Crook T. Global Deterioration Scale (GDS). Psychopharmacol Bull 1988;24:661-662.
21. Reisberg B, Schneider L, Doody R, et al. Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord 1997;11(suppl 3):8-18.
22. Mattis S. Dementia Rating Scale. Professional Manual. Odessa FL: Psychological Assessment Resources, Inc., 1988.
23. Ballard C, Walker M, O'Brien J, Rowan E, McKeith I. The characterization and impact of "fluctuating" cognition in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2001;16:494-498.
24. Walker MP, Ayre GA, Perry EK, et al. Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 2000;11:327-335.
25. Ballard CG, Aarsland D, McKeith I, et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 2002;59:1714-1720.
26. Ballard C, O'Brien J, Gray A, et al. Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer's disease. Arch Neurol 2001;58:977-982.
27. Dickson DW, Davies P, Mayeux R, et al. Diffuse Lewy body disease: neuropathological and biochemical studies of six patients. Acta Neuropathol 1987;75:8-15.
28. Perry EK, Irving D, Kerwin J, et al. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer's disease. Alzheimer Dis Assoc Disord 1993;7:69-79.
29. Perry EK, Perry RH. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn 1995;28:240-258.
30. Perry EK, Walker MP, Grace J, Perry R. Acetylcholine in mind: a neurotransmitter correlate of consciousness. Trends Neurosci 1999;22:273-280.
31. Davis KL, Mohs RC, Marin D, et al. Cholinergic markers in elderly patients with early signs of Alzheimer's disease. JAMA 1999;281:1401-1406.
32. Ballard CG, Court JA, Piggott M, et al. Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex. Conscious Cogn 2002;11:461-474.
33. Itil T, Fink M. Anticholinergic drug-induced delirium: experimental modification, quantitative EEG and behavioral correlations. J Nerv Ment Dis 1966;143:492-507.
34. Flacker J, Cummings V, Mach JR, Bettin K, Kiely D, Wei J. The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry 1998;6:31-41.
35. Ling H, McCusker J, Cole M, et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001;161:1099-1105.
36. Tune LE, Holland A, Folstein M, Damlouji N, Gardner T, Coyle J. Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet 1981;2:651-652.
37. Wengel SP, Roccaforte WH, Burke WJ. Donepezil improves symptoms of delirium in dementia: implications for future research. J Geriatr Psychiatry Neurol 1998;11:159-161.
38. Shea C, MacKnight C, Rockwood K. Donepezil for treatment of dementia with Lewy bodies: a case series of 9 patients. Int Psychogeriatr 1998;10:229-238.
39. McKeith I, DelSer T, Spano P, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomized, double-blind, placebo-controlled international study. Lancet 2000;356:2031-2036.